PMEF
AZN icon

Point72 Middle East FZE’s AstraZeneca AZN Stock Holding History

Point72 Middle East FZE’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,064
Closed -$3.94M – 1502
2023
Q3 		$3.94M Sell
29,064
-31,085
-52% -$4.25M 0.13% 203
2023
Q2 		$8.61M Buy
+60,149
New +$8.85M 0.24% 100
2023
Q1 		– Sell
-17,921
Closed -$2.43M – 1646
2022
Q4 		$2.43M Buy
+17,921
New +$2.25M 0.11% 258

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Middle East FZE's AZN Position: Q4 2023 in Review

Point72 Middle East FZE sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 29,064 shares — an estimated $3.94M sold.

Point72 Middle East FZE first reported a position in AZN in Q4 2022 and held it in 3 quarters. The position peaked at $8.61M in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • Point72 Middle East FZE reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 29,064 AstraZeneca shares in Q4 2023, an estimated $3.94M.
  • Point72 Middle East FZE first reported a position in AstraZeneca in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's AstraZeneca position peaked at $8.61M in Q2 2023.
  • 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.